))
Developing a Strategy for Obtaining Real World Evidence: A Conversation with Kari Kalgren from Premier Applied Sciences
Archived series ("Inactive feed" status)
When?
This feed was archived on October 30, 2022 08:45 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 296153379 series 2916645
Content provided by PM 411 Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PM 411 Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
One problem that all pharmaceutical marketers face is how to convince payers that their innovative treatment is worth paying for. In order to make a compelling argument, pharma must develop a pipeline of "real-world evidence" that demonstrates the utility of treatments and their impact on cost. Kari Kalgrem from Premier Applied Sciences is working with the pharmaceutical industry on this important work that will help increase patient access.
24 episodes
Share
